Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Marex Group has filed a Form 144 notice for the proposed sale of 210,000 shares of common stock through J.P. Morgan Securities, with an aggregate market value of $8,219,400. The sale is scheduled for June 23, 2025, on the Nasdaq exchange.
The securities to be sold were acquired through multiple compensation grants:
- May 2024: 29,243 shares total
- March 2025: 105,122 shares total
- May 2025: 75,635 shares
The total shares outstanding are 71,231,706. The proposed sale represents approximately 0.29% of outstanding shares. No securities were reported sold by the filer during the past three months. This Form 144 filing indicates insider's intention to sell while affirming no knowledge of undisclosed material adverse information about the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many Marex Group (MRX) SEC filings are available on StockTitan?
StockTitan tracks 274 SEC filings for Marex Group (MRX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for Marex Group (MRX)?
The most recent SEC filing for Marex Group (MRX) was filed on July 28, 2025.